These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 4774187)
1. Are class 1 and class 2 Pap smears objectively interpreted? Berube LW Md State Med J; 1973 Sep; 22(9):54-8. PubMed ID: 4774187 [No Abstract] [Full Text] [Related]
2. Companies build Pap smear safety nets. Scott L Mod Healthc; 1995 May; 25(19):70. PubMed ID: 10142267 [No Abstract] [Full Text] [Related]
3. Pap smear concerns. Moran T Tex Med; 1997 Nov; 93(11):44-6. PubMed ID: 9369088 [No Abstract] [Full Text] [Related]
4. Pap smear furor may derail Clinton changes. Scott L Mod Healthc; 1993 Oct; 23(40):17. PubMed ID: 10171532 [No Abstract] [Full Text] [Related]
5. Random rescreening of cytologic smears: a practical and effective component of quality assurance programs in both large and small cytology laboratories. Krieger P; Naryshkin S Acta Cytol; 1994; 38(3):291-8. PubMed ID: 8191815 [No Abstract] [Full Text] [Related]
6. [External quality control in cervical cytopathology: an evaluation from 2000-2004]. Rev Saude Publica; 2007 Dec; 41(6):1071. PubMed ID: 18066478 [No Abstract] [Full Text] [Related]
7. Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears. Arbyn M; Schenck U; Ellison E; Hanselaar A Cancer; 2003 Feb; 99(1):9-16. PubMed ID: 12589640 [TBL] [Abstract][Full Text] [Related]
8. Quality evaluation of cytology laboratories in New York State: expanded program, 1971-73. Collins DN; Kaufmann W; Clinton W Acta Cytol; 1974; 18(5):404-13. PubMed ID: 4140649 [No Abstract] [Full Text] [Related]
9. European guidelines on cervical screening. Smith JH; Desai MS Cytopathology; 2007 Aug; 18(4):211-2. PubMed ID: 17635160 [No Abstract] [Full Text] [Related]
10. Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88). Austin RM Med Care; 1994 Oct; 32(10):1064-5. PubMed ID: 7934273 [No Abstract] [Full Text] [Related]
11. Study proposes Pap smears at 3-year intervals. AIDS Read; 2000 Nov; 10(11):643. PubMed ID: 11186186 [No Abstract] [Full Text] [Related]
12. [Cervical smears and evaluation of quality]. Marsan C Ann Pathol; 1996 Nov; 16(5):344-9. PubMed ID: 9004721 [No Abstract] [Full Text] [Related]
13. The adequacy of Papanicolaou smears as performed by family physicians and obstetrician-gynecologists. Fiscella K; Franks P J Fam Pract; 1999 Apr; 48(4):294-8. PubMed ID: 10229255 [TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049 [TBL] [Abstract][Full Text] [Related]
15. Does a zero error standard exist for the Papanicolaou smear? A pathologist's perspective. Frable WJ Arch Pathol Lab Med; 1997 Mar; 121(3):301-10. PubMed ID: 9111124 [TBL] [Abstract][Full Text] [Related]
16. [Cervical screening--its essence and quality-control methodology in cytology laboratories]. Kostova P Akush Ginekol (Sofiia); 1998; 37(4):58-61. PubMed ID: 10360060 [TBL] [Abstract][Full Text] [Related]
17. Optimal collection technique and devices for a quality pap smear. Marchand L; Mundt M; Klein G; Agarwal SC WMJ; 2005 Aug; 104(6):51-5. PubMed ID: 16218317 [TBL] [Abstract][Full Text] [Related]
18. The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities. Mintzer M; Curtis P; Resnick JC; Morrell D Cancer; 1999 Jun; 87(3):113-7. PubMed ID: 10385441 [TBL] [Abstract][Full Text] [Related]
19. Pap smears: quality, not only quantity. Ward J; Farnsworth A; Grace J; Ford J Aust Fam Physician; 1990 Feb; 19(2):109. PubMed ID: 2322178 [No Abstract] [Full Text] [Related]
20. Patient age and adequacy of Pap smears. Aaen V; Ferry L Am Fam Physician; 1993 Feb; 47(3):585-6, 588. PubMed ID: 8434549 [No Abstract] [Full Text] [Related] [Next] [New Search]